References
Katsanos K, et al. Risk of death and amputation with use of paclitaxel-coated balloons in the infrapopliteal arteries for treatment of critical limb ischemia: a systematic review and meta-analysis of randomized controlled trials. J Vasc Interv Radiol. 2020;31(2):202–12.
Katsanos K, et al. Risk of death following application of paclitaxel-coated balloons and stents in the femoropopliteal artery of the leg: a systematic review and meta-analysis of randomized controlled trials. J Am Heart Assoc. 2018;7(24):e011245.
Zeller T, et al. Drug-eluting balloon versus standard balloon angioplasty for infrapopliteal arterial revascularization in critical limb ischemia: 12-month results from the IN.PACT DEEP randomized trial. J Am Coll Cardiol. 2014;64(15):1568–76.
Mustapha JA, et al. Drug-coated vs uncoated percutaneous transluminal angioplasty in infrapopliteal arteries: six-month results of the lutonix BTK trial. J Invasive Cardiol. 2019;31(8):205–11.
Reijnen M, et al. Outcomes after drug-coated balloon treatment of femoropopliteal lesions in patients with critical limb ischemia: a post hoc analysis from the INPACT global study. J Endovasc Ther. 2019;26(3):305–15.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Tepe, G. Increased Risk of Using Drug-Eluting Balloons Below the Knee? The Discussion Continues. Cardiovasc Intervent Radiol 43, 948–949 (2020). https://doi.org/10.1007/s00270-020-02447-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00270-020-02447-z